18-Methylsegesterone acetate
18-Methylsegesterone acetate[edit]
18-Methylsegesterone acetate is a synthetic progestin of the 19-norprogesterone group. It is a derivative of segesterone acetate, which is used in various hormonal contraceptive formulations. This compound is notable for its high potency and selectivity as a progestogen.
Chemical Structure[edit]
18-Methylsegesterone acetate is characterized by its unique chemical structure, which includes a methyl group at the 18th position. This modification enhances its progestogenic activity and reduces its androgenic and estrogenic effects compared to other progestins.
Pharmacology[edit]
As a progestin, 18-Methylsegesterone acetate acts primarily on the progesterone receptor. It mimics the effects of progesterone, a natural hormone involved in the menstrual cycle, pregnancy, and embryogenesis. The compound is used in contraceptive methods due to its ability to inhibit ovulation and alter the endometrium to prevent implantation.
Clinical Use[edit]
While 18-Methylsegesterone acetate itself is not widely used in clinical practice, its parent compound, segesterone acetate, is utilized in contraceptive implants and vaginal rings. These delivery systems provide long-acting and reversible contraception, offering an alternative to daily oral contraceptives.
Mechanism of Action[edit]
The primary mechanism of action of 18-Methylsegesterone acetate involves binding to the progesterone receptor, leading to changes in gene expression that result in the suppression of gonadotropin release. This suppression prevents the ovarian follicle from maturing and releasing an ovum, thereby preventing fertilization.
Side Effects[edit]
As with other progestins, potential side effects of 18-Methylsegesterone acetate may include menstrual irregularities, headaches, nausea, and breast tenderness. However, its specific side effect profile is not well-documented due to limited clinical use.
Related Compounds[edit]
Related Pages[edit]
-
18-Methylsegesterone acetate
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
